Previous
Previous

Eagle Genomics Selected for Catalonia-Based Initiative to Support Expansion into Spanish-Speaking Markets

Next
Next

Arecor commences US Phase I clinical trial of AT247 ultra-rapid insulin in combination with an insulin pump